Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
1995-7-25
pubmed:abstractText
Carbohydrate antigens rarely provide target epitopes for cytotoxic T lymphocytes (CTL). Disialoganglioside GD2 is a glycolipid expressed at high levels in human tumors and a small group of murine lymphomas (EL4, RBL5, RMA, RMA-S, A13, and BALBRVE). Immunization of C57B1/6 mice with irradiated EL4 cells stimulated a specific CTL response and protected these animals from engraftment of EL4 lymphoma. The CTL activity resided in the CD4-CD8+ population, was dependent on T cell receptor alpha/beta, and was not removed by anti-natural killer cell immunoabsorption, but was restricted to GD2 and H-2b bearing targets. CTL activity could be completely inhibited by GD2-oligosaccharide-specific monoclonal antibodies and their F(ab')2 fragments, but not by immunoglobulin G3 myelomas or antibodies against GD3 or GM2. Soluble GD2 did not inhibit specific tumor lysis. RMA-S lymphoma cells (GD2+H-2b-TAP2 deficient) were resistant to GD2-specific CTL. Sialic acid-containing peptides eluted from EL4 lymphoma cells could (a) stabilize H-2 molecules on RMA-S cells and (b) sensitize them for GD2-specific CTL. Control peptides (derived from vesicular stomatitis virus nucleoprotein peptide and GD2-negative lymphomas) could also stabilize H-2 on RMA-S, but were resistant to GD2-specific CTL. These H-2-binding peptides could be purified by anti-GD2 affinity chromatography. We postulate a new class of naturally occurring epitopes for T cells where branched-chain oligosaccharides are linked to peptides with anchoring motifs for the major histocompatibility complex class I pocket. While analogous to the haptens trinitrophenyl and O-beta-linked acetyl-glucosamine, the potential implications of natural carbohydrates as antigenic epitopes for CTL in biology are considerable.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/7540657-1320641, http://linkedlifedata.com/resource/pubmed/commentcorrection/7540657-1335364, http://linkedlifedata.com/resource/pubmed/commentcorrection/7540657-1384686, http://linkedlifedata.com/resource/pubmed/commentcorrection/7540657-1402688, http://linkedlifedata.com/resource/pubmed/commentcorrection/7540657-1442305, http://linkedlifedata.com/resource/pubmed/commentcorrection/7540657-1623478, http://linkedlifedata.com/resource/pubmed/commentcorrection/7540657-1659106, http://linkedlifedata.com/resource/pubmed/commentcorrection/7540657-1730513, http://linkedlifedata.com/resource/pubmed/commentcorrection/7540657-1793158, http://linkedlifedata.com/resource/pubmed/commentcorrection/7540657-1840703, http://linkedlifedata.com/resource/pubmed/commentcorrection/7540657-2358681, http://linkedlifedata.com/resource/pubmed/commentcorrection/7540657-2415471, http://linkedlifedata.com/resource/pubmed/commentcorrection/7540657-2435716, http://linkedlifedata.com/resource/pubmed/commentcorrection/7540657-2450893, http://linkedlifedata.com/resource/pubmed/commentcorrection/7540657-2452012, http://linkedlifedata.com/resource/pubmed/commentcorrection/7540657-2452202, http://linkedlifedata.com/resource/pubmed/commentcorrection/7540657-2467945, http://linkedlifedata.com/resource/pubmed/commentcorrection/7540657-2505918, http://linkedlifedata.com/resource/pubmed/commentcorrection/7540657-2953613, http://linkedlifedata.com/resource/pubmed/commentcorrection/7540657-3115567, http://linkedlifedata.com/resource/pubmed/commentcorrection/7540657-3260628, http://linkedlifedata.com/resource/pubmed/commentcorrection/7540657-6296843, http://linkedlifedata.com/resource/pubmed/commentcorrection/7540657-7681423, http://linkedlifedata.com/resource/pubmed/commentcorrection/7540657-7690810, http://linkedlifedata.com/resource/pubmed/commentcorrection/7540657-8046349, http://linkedlifedata.com/resource/pubmed/commentcorrection/7540657-8335903, http://linkedlifedata.com/resource/pubmed/commentcorrection/7540657-8375931, http://linkedlifedata.com/resource/pubmed/commentcorrection/7540657-8402683, http://linkedlifedata.com/resource/pubmed/commentcorrection/7540657-8405061, http://linkedlifedata.com/resource/pubmed/commentcorrection/7540657-8476563, http://linkedlifedata.com/resource/pubmed/commentcorrection/7540657-8509225
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
0022-1007
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
182
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
67-74
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed-meshheading:7540657-Animals, pubmed-meshheading:7540657-Antigens, Neoplasm, pubmed-meshheading:7540657-Epitopes, pubmed-meshheading:7540657-Gangliosides, pubmed-meshheading:7540657-H-2 Antigens, pubmed-meshheading:7540657-Immunization, pubmed-meshheading:7540657-Leukemia, Basophilic, Acute, pubmed-meshheading:7540657-Lymphoma, pubmed-meshheading:7540657-Mice, pubmed-meshheading:7540657-Mice, Inbred BALB C, pubmed-meshheading:7540657-Mice, Inbred C57BL, pubmed-meshheading:7540657-Mice, Inbred DBA, pubmed-meshheading:7540657-Mice, Nude, pubmed-meshheading:7540657-Neoplasm Transplantation, pubmed-meshheading:7540657-Neurons, pubmed-meshheading:7540657-Rats, pubmed-meshheading:7540657-Receptors, Antigen, T-Cell, alpha-beta, pubmed-meshheading:7540657-T-Lymphocytes, Cytotoxic, pubmed-meshheading:7540657-Tumor Cells, Cultured
pubmed:year
1995
pubmed:articleTitle
GD2 oligosaccharide: target for cytotoxic T lymphocytes.
pubmed:affiliation
Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York 10021, USA.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't